- Almost half of people with multiple sclerosis leave the workplace within three years of being diagnosed1
- Merck Serono leads the way in partnering with Microsoft, European Federation of Neurological Associations and Employers’ Forum on Disability to form the ms&work coalition
Friday, 21 October 2011
New Coalition to Address the Needs of People with Multiple Sclerosis in the Workplace
LONDON--(BUSINESSWIRE)--
Oral BG-12 (Dimethyl Fumarate) Significantly Reduced Multiple Sclerosis (MS) Relapses and Disability Progression in Define Phase 3 Clinical Trial
Biogen Idec (NASDAQ: BIIB) announced positive data from the Phase 3 DEFINE clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS). Results showed that 240 mg of BG-12, administered either twice a day (BID) or three times a day (TID), significantly reduced the proportion of patients who relapsed by 49 percent and 50 percent, respectively, at two years compared with placebo. For more click here.
Do you know anyone who would like to join the MS Centre's Reading Half Marathon running team for the 2012
We have Gold Bond places available for those who want to raise funds for the Centre at Reading's highest profile event. Please call Jackie at the Centre for more information or email jackie@bmstc.org
Gilly raises £2500 for BMSTC walking the Inca Trail!
Thursday, 20 October 2011
Researchers observed both remyelination indicative of repair and a drastic reduction of demyelination and axonal loss in mice treated with COPAXONE(R).
(NASDAQ: TEVA) today announced preclinical data demonstrating reparative and neuroprotective effects of treatment with COPAXONE(R) (glatiramer acetate injection) in experimental autoimmune encephalomyelitis (EAE) models. In the study, researchers compared mice treated with COPAXONE(R) versus non-treated mice in relapsing-remitting and chronic multiple sclerosis (MS) disease models. Read more here.
Tuesday, 18 October 2011
MS respite care centres set to close
Source The MS Society:
The MS Society regrets to announce that Brambles Respite Care Centre in Horley, Surrey, and Helen Ley Care Centre in Leamington Spa, Warwickshire, are both set to close within the next few months. Read more here.
The MS Society regrets to announce that Brambles Respite Care Centre in Horley, Surrey, and Helen Ley Care Centre in Leamington Spa, Warwickshire, are both set to close within the next few months. Read more here.
Come and join in this consultation workshop on Long Term Neurological Conditions
Within Berkshire West PCT area we are undertaking a Quality Neurology
Assessment with the help of the Neurological Commissioning Support Group.
This will give a view of the current picture of services compared to
recommendations in the National Service Framework and also enable effective
planning for future service design. We have a workshop for Clinicians and
Therapists and are also holding one for Service Users and Carers.
The Service Users / Carer Workshop is for anyone who is affected by any Long Term Neurological Condition.
Venue:
Thursday 3rd November 2011
T hank
you for your assistance.
Public Health, NHS Berkshire West,57-59 Bath Road , Reading , RG30 2BA
ÉTel: 0118
982 2757 / 07795 044409 ÊFax: 0118
982 2914
The Service Users / Carer Workshop is for anyone who is affected by any Long Term Neurological Condition.
Venue:
MS
Therapy Centre, Bradbury House, 23a August End, Brock, Gardens, Reading , RG30
2JP
Thursday 3rd November 2011
5pm
Arrival with Sandwiches & Cake
5.30pm
Start
7.30pm
latest finish for the workshop
7.30
- 8.15pm opportunity to network with other Service Users / Carers or have an
individual chat with the NCS
Friday
4th November 2011
9.30am
Arrival,
coffee and biscuits
10am
start of workshop
12
noon
Latest finish for the workshop
12-12.30
Opportunity to network with other Service Users
/ Carers or to have an individual chat with the NCS
Anyone
wishing to attend does need to register and indicate if you will be accompanied
by a carer – for catering. deborah.matthews@csupport.org.uk
or helene.raynsford@berkshire.nhs.uk
07795 044409
Best
wishes
Helene
Helene Raynsford
Locality Public Health Lead - Wokingham / Older People
Public Health, NHS Berkshire West,
Christmas Fayre 19th November - Letter to you from our Link Group
Hello
Everyone
Once again we are planning the Christmas Fayre and this year local MP Alok Sharma will perform the opening ceremony. As usual we are asking for your help. Please will you donate any of the following?
There is a labelled plastic dustbin in the reception area at the Centre into which donated items can be placed. Wine should be given direct to Trish Wright or handed to Tracy or Jackie who will pass it on to her. Cakes should be brought along on the day, or a day or two before.
Other ways you can help
Please come along on the day with your friends and family. You will find lots of stalls with all sorts of things to buy and delicious cakes to eat in or take away. Tea, coffee and cold drinks will also be available and of course Santa will be there in his grotto.
Many thanks for your support and we look forward to seeing as many of you as possible at the Fayre.
Sue Smith
BMSTC Members' Link Group
Re: CHRISTMAS FAYRE - 19 November
2011, 1 - 3.30pm
Once again we are planning the Christmas Fayre and this year local MP Alok Sharma will perform the opening ceremony. As usual we are asking for your help. Please will you donate any of the following?
- A prize for the raffle or tombola. (Any new, unused, items would
be very welcome.)
- Soft Toys which can be used as prizes.
- Wine for prizes in the Wine Raffle
- Cakes to serve with tea and coffee on the day and for
people to buy and take home.
There is a labelled plastic dustbin in the reception area at the Centre into which donated items can be placed. Wine should be given direct to Trish Wright or handed to Tracy or Jackie who will pass it on to her. Cakes should be brought along on the day, or a day or two before.
Other ways you can help
Are you or
any of your family and friends available to help on the day? We need able-bodied people to help set up the tables from 9 am to 11 am. Also help is needed at the end of the day
(dismantling tables and clearing up) from about 3pm to 5pm. If you or anyone
you know could help with this (or in any other way) there is a volunteers' form
at the Centre for you to complete or please phone the Centre.
Please come along on the day with your friends and family. You will find lots of stalls with all sorts of things to buy and delicious cakes to eat in or take away. Tea, coffee and cold drinks will also be available and of course Santa will be there in his grotto.
Many thanks for your support and we look forward to seeing as many of you as possible at the Fayre.
Sue Smith
BMSTC Members' Link Group
Monday, 17 October 2011
Melbourne Brain Centre opens in Parkville with 700 research staff
Source News.com.au
THE world's fifth largest brain research centre has opened in Victoria.
The $225 million Melbourne Brain Centre in Parkville will host 700 staff, who will research conditions including multiple sclerosis, stroke, Alzheimer's disease and epilepsy. Read more here.
THE world's fifth largest brain research centre has opened in Victoria.
The $225 million Melbourne Brain Centre in Parkville will host 700 staff, who will research conditions including multiple sclerosis, stroke, Alzheimer's disease and epilepsy. Read more here.
MS Society calls for Quality Standard for MS
The MS Society has called for the urgent development of a Quality Standard for MS to set a benchmark to address the variation in care received by people with MS. Read more here.
Update on our appeal to support MS nurses
We sent out an appeal earlier this year to raise funds towards our MS Nurse Support Programme. Thanks to everyone has who responded so far, we have raised over £35,000 and we have been putting these donations to work. Read more here.
Thursday, 13 October 2011
Lord Walton of Detchant asks why the UK is slow to adopt remedies for multiple sclerosis compared with its European neighbours.
Multiple sclerosis is one of the commonest disabling neurological disorders, in which plaques of demyelination (degeneration of myelin sheaths of nerve fibres) develop in various parts of the brain and spinal cord. It is variable in its incidence and severity, in that some cases are relatively mild, some run a relapsing and remitting course with substantial intervals between episodes, which nevertheless lead to progressive disability, while in other patients the condition is rapidly progressive, with few if any remissions. Read more here.
Would you like to take part in this research study?
Gowrings Mobility Stock Clearance January Sale in Newbury
Don't miss the Great Gowrings Mobility Stock Clearance Sale. Fantastic clearance bargains for three days only.
Gowrings Mobility Showroom, Newbury, Berkshire.10am-4pm, Tuesday 10th, Wednesday 11th and Thursday 12th January 2012. See more details here!
Wednesday, 12 October 2011
Simvastatin study improves vision in optic neuritis
A recent study suggests that simvastatin, a drug commonly used to lower cholesterol levels, may be an effective treatment for people with acute optic neuritis. Read more here.
BMSTC is one of the official charities for the Reading Half Marathon!
Tuesday, 11 October 2011
Christmas Cards!
http://www.charitychristmascards.com/charitychoice We are listed as Berkshire MS Therapy Centre and there is a 10% discount for cards bought before the end of October! :0)
Monday, 10 October 2011
NHS 'fails people with MS'
NHS services for people with multiple have barely improved in the past five years, according to a national audit conducted by the Royal College of Physicians and the MS Trust.
Professor Derick Wade, who took part in conducting the audit, explains the findings. Click here to listen.
Care for multiple sclerosis patients unchanged in five years
Care for people with multiple sclerosis has not improved over the past five years, according to a report, with many still struggling to access services that would improve their condition. Read article here.
The Regional Driving Assessment Centre
For more information see their website here.
NHS services for multiple sclerosis patients remain poor
Services that people with multiple sclerosis depend upon from the NHS have shown little or no improvement in the last five years, and guidelines issued by NICE for the management of patients with MS are no closer to being met today than when they were first launched in 2003. Read article here.
Livabiltiy are offering a 10% discount on their holidays booked between now and the end of January 2012
Livability gives disabled and disadvantaged people real choice about how they live their lives. As the UK’s largest Christian disability charity, we run a wide range...Read more here.
Friday, 7 October 2011
Blue Badge Scheme Changes
The Blue Badge Scheme is changing - Reading Borough Council are holding an information and advice event so that you can find out how these changes may affect you and find out about mobility assessments and accesible transport. 16th November, 11.00am - 1.15pm, Kennet Room, Civic Offices, Reading. Book your place 0118 927 2383 or email housingccstrategyteam@reading.Thursday, 6 October 2011
Sheltered Housing Services Consultation
Reading Borough Council are holding a consulation on their sheltered housing services, including asking if it should be made available to people under retirement age.
For more information please click here.
For more information please click here.
Wednesday, 5 October 2011
Anti-inflammatory drug 'reduces MS relapses'
5th October 2011 - Patients with MS who took the new generation anti-inflammatory medication natalizumab for two years had a lower risk of experiencing relapses and progression of their disability, according to a new study. Read more here.
Analysis of CCSVI studies suggest strong association with MS
A meta-analysis of eight studies of chronic cerebro-spinal venous insufficiency which compared people with MS to healthy controls or those with other neurological conditions found CCSVI more common in people with MS. For more click here.
Merck, Ono developing oral multiple sclerosis drug
Source SFGate:
Merck KGaA said its Merck Serono unit will develop and market a pill for multiple sclerosis with Japan's Ono Pharmaceutical Co. to compete with a similar product made by Novartis AG. For more click here.
IT Can help - Free local computer assistance to disabled people
Tuesday, 4 October 2011
Research into controversial MS treatment still too conflicting, study finds
A new study attempting to evaluate the validity of research into the prevalence of blocked veins in multiple sclerosis patients has concluded the evidence is too conflicting and inconsistent to draw any concrete conclusions.
The study, published Monday in the Canadian Medical Association Journal, adds another layer of uncertainty to the controversy surrounding the contentious issue, which has been brewing for about two years following media reports of the possible link between blocked veins and MS. Read more here.
Carmel Turner's Stem Cell Story
Very interesting story about Carmel Turner which we picked up in the new Pathways magazine. Carmel is the second person in Australia to undergo Haematopoietic Stem Cell Transplantation (HSCT).
Scroll down in the link to read the article and the symptom imrovements that Carmel has experienced. Read here.
Monday, 3 October 2011
MS centre faces uncertain future
A respite care centre for people with multiple sclerosis in Warwickshire is facing an uncertain future after a potential sale fell through. Read more here.
Chief Medical Officer: Russian roulette to avoid flu jab
People are more likely to get the vaccinations they need before going on holiday than the winter flu jab, it is claimed, prompting Government accusations that they are “playing Russian roulette with their lives”. Read more here.
Fampridine, a drug that can improve walking in MS, has been launched in the UK.
Fampridine, a drug that can improve walking in MS, has been launched in the UK.
Fampridine, taken as one 10mg tablet twice daily, was granted a conditional marketing authorisation by the European Commission in July 2011 to improve walking in adult patients with MS who have walking disability (defined as scoring 4-7 on the Expanded Disability Status Scale). For more click here.
Subscribe to:
Posts (Atom)
